Autologous PBSCT in patients with cardiac amyloidosis.
Stevens
J M
JM
Patton
W N
WN
Heaton
D C
DC
Spearing
R L
RL
Shaw
G
G
Bowie
D
D
Smyth
D
D
Comenzo
R
R
D000686:Amyloidosis / Q000150:complications / Q000628:therapy*; D018952:Antigens, CD34 / Q000032:analysis; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage / Q000633:toxicity; D001804:Blood Transfusion, Autologous; D009202:Cardiomyopathies / Q000150:complications / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008297:Male; D008558:Melphalan / Q000008:administration & dosage / Q000633:toxicity; D008875:Middle Aged; D012770:Shock, Cardiogenic / Q000139:chemically induced; D013234:Stem Cells / Q000276:immunology
D018952:Antigens, CD34; D018906:Antineoplastic Agents, Alkylating; D008558:Melphalan